Morgan Stanley Keeps Globe Life at Equal-Weight, Raises PT to $127

Morgan Stanley Keeps Globe Life at Equal-Weight, Raises PT to $127

On Monday, July 1st, Morgan Stanley increased its price target for Globe Life (NYSE:GL) to $127, maintaining its "equal weight" rating on the stock. This adjustment comes after a series of recent changes in analyst ratings and price targets from other major financial institutions. Morgan Stanley's move follows a pattern of increased optimism among analysts regarding Globe Life's potential.

In the past few weeks, several key analysts have revised their ratings and price targets for Globe Life. JPMorgan Chase & Co. raised its price target to $160, while Wells Fargo & Company reduced its target to $139. Wall Street Zen upgraded Globe Life to a "buy" rating, and Piper Sandler lowered its target to $147. Despite these changes, Morgan Stanley's decision to keep the stock at "equal weight" reflects a more cautious stance compared to the bullish ratings from other firms.

Globe Life's recent earnings report, released on April 30th, showed earnings per share of $3.07, missing the consensus estimate of $3.24. However, the company reported a 4.5% increase in revenue year-over-year, reaching $1.48 billion. The firm also declared a quarterly dividend of $0.27 per share, with an annualized payout of $1.08 and a dividend yield of 0.91%.

The company's financial health is indicated by a quick ratio of 0.07, a current ratio of 0.07, and a debt-to-equity ratio of 0.43. Its market capitalization stands at $9.76 billion, with a P/E ratio of 9.62 and a beta of 0.56. The business's 50-day moving average price is $120.95, and its 200-day moving average price is $121.16.

Institutional investors have shown interest in Globe Life, with 81.61% of the stock owned by institutions. Insider activity includes CEO Frank M. Svoboda selling 6,019 shares on May 20th, representing a 16.13% decrease in his ownership. The average rating among analysts is "Moderate Buy," with a price target of $139.55.

The recent changes in analyst ratings and price targets for Globe Life reflect a mix of optimism and caution. While several firms have raised their targets, Morgan Stanley's decision to maintain an "equal weight" rating suggests a more balanced view of the stock's potential. Investors should consider these updates when evaluating Globe Life's prospects.

References:
[1] https://www.marketbeat.com/instant-alerts/jpmorgan-chase-co-increases-globe-life-nysegl-price-target-to-16000-2025-07-08/